Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
LAVAL, Quebec, October 9, 2024 – Bausch Health Companies Inc. (NYSE/TSX: BHC) will release third quarter 2024 financial results after market close on Wednesday, October 30, 2024. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
2024年10月9日,博士健康公司(紐約證券交易所/多倫多證券交易所:BHC)將於2024年10月30日(週三)市場收盤後公佈第三季度2024年財務業績。博士健康將於美國東部時間下午5:00舉行電話會議和現場網絡廣播,討論業績並提供業務更新。會議前所有材料將在博士健康網站的投資者關係部分提前提供。
Conference Call Details
電話會議詳情
Date: |
Wednesday, October 30, 2024 |
Time: |
5:00 p.m. U.S. EST |
Webcast: |
日期: |
2024年10月30日,星期三 |
時間: |
美國東部時間下午5:00 |
網絡直播: |
A replay of the conference call will be available on the investor relations website.
電話會議的錄音重播將在投資者關係網站上提供。
To participate in the live Q&A session, please register using this link to receive an email confirming your registration with further details.
要參加現場問答環節,請使用此鏈接註冊,以便收到確認註冊的電子郵件及進一步詳細信息。
About Bausch Health
關於Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit and connect with us on LinkedIn.
bausch health公司(紐交所/tsx: BHC)是一家全球多元化的藥品公司,通過我們不懈的努力致力於提供更好的醫療保健成果,豐富人們的生活。我們主要在胃腸病學、肝病學、神經病學、皮膚科、醫學美容器械、國際藥品和眼部健康領域開發、生產和銷售一系列產品,通過對Bausch + Lomb的控股權。我們的抱負是成爲一家全球一體化的醫療保健公司,受患者、醫療專業人士、員工和投資者信賴和重視。欲了解更多信息,請訪問 ,並在LinkedIn上與我們聯繫。
Investor Contact: | Media Contact: |
Garen Sarafian ir@bauschhealth.com (877) 281-6642(toll-free) |
Katie Savastano corporate.communications@bauschhealth.com (908) 541-3785 |
投資者聯繫人: | 媒體聯繫人: |
加倫·薩拉菲安 ir@bauschhealth.com (877)281-6642(免費電話) |
Katie Savastano corporate.communications@bauschhealth.com (908)541-3785 |
譯文內容由第三人軟體翻譯。